✦ LIBER ✦

A double-blind, placebo-controlled, randomized, crossover pilot study of the safety and efficacy of multiple doses of intra-oral tropicamide films for the short-term relief of sialorrhea symptoms in Parkinson's disease patients

✍ Scribed by Santiago Perez Lloret; Gabriela Nano; Andrea Carrosella; Elkan Gamzu; Marcelo Merello

Book ID: 119304114
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 184 KB
Volume: 310
Category: Article
ISSN: 0022-510X
DOI: 10.1016/j.jns.2011.05.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of intranasal ketami

Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study

✍ Daniel B Carr; Leonidas C Goudas; William T Denman; Daniel Brookoff; Peter S Sta 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 163 KB

A multicentre, randomized, double-blind,

A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study

✍ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre